Chlorpromazine in the treatment of endogenous organic hyperinsulinism.
D000328:Adult; D001539:Bendroflumethiazide / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005951:Glucose Tolerance Test; D006628:Hirsutism / Q000139:chemically induced; D006801:Humans; D006946:Hyperinsulinism / Q000188:drug therapy*; D007003:Hypoglycemia / Q000188:drug therapy; D007329:Insulin Antagonists; D009325:Nausea / Q000139:chemically induced; D010179:Pancreas / Q000601:surgery
D001786:Blood Glucose; D007329:Insulin Antagonists; D001539:Bendroflumethiazide; D003981:Diazoxide; D002746:Chlorpromazine